Immunomodulating effect of influenza vaccination in the elderly differing in health status

Experimental Gerontology

Volumn 39, Issue 10, 2004, Pages 1447-1458

  Mysliwska J ^a   Trzonkowski, P ^a   Szmit, E ^a   Brydak, L B ^b   Machala M ^b   Mysliwski A ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Elderly; Influenza; NK activity; Vaccination

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; TRIPLE VACCINE;

AGED; ANTIBODY TITER; ARTICLE; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; EPIDEMIC; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, VIRAL; CELLS, CULTURED; CHRONIC DISEASE; CYTOTOXICITY, IMMUNOLOGIC; DISEASE OUTBREAKS; FEMALE; HEALTH STATUS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; POLAND; RESPIRATORY TRACT INFECTIONS; VACCINATION;

EID: 6944233880     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2004.08.005     Document Type: Article

References (46)

1. Y. Amakata, Y. Fujiyama, A. Andoh, K. Hodohara, and T. Bamba Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes Clin. Exp. Immunol. 124 2001 214 222
2. D.J.S. Arora, and D.M. Justewicz Human influenza viral neuraminidases augment cell mediated cytotoxicity in vitro Nat. Immun. Cell Growth Regul. 7 1988 87 94
3. + cytolytic T cell responses J. Exp. Med. 182 1995 1663 1671
4. H.F. Berg, J. Van Gendt, G.F. Rimmelzwaan, M.F. Peeters, and P. Van Keulen Nosocomial influenza infection among post-influenza-vaccinated patients with severe pulmonary diseases J. Infect. 46 2002 129 132
5. C.A. Biron Activation and function of natural killer cell responses during viral infections Curr. Opin Immunol. 9 1997 24 34
6. + B cells J. Immunol. 167 2001 6132 6139
7. A. Bot, A. Reichlin, H. Isobe, S. Bot, J. Schulman, and V.M. Yokoyama Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice J. Virol. 70 1996 5668 5672
8. S.C.C. Castle Clinical relevance of age-related immune dysfunction Clin. Infect. Dis. 31 2000 578 585
9. S.B. Cheknev Measurement of NK cells cytotoxicity and IFN production are square of the area under the functional curve Russ. J. Immunol. 7 2002 123 128
10. Concepts and Procedures for Laboratory-Based Influenza Surveillance. July 1982. WHO Collaborating Centres for Reference and Research on Influenza. US Department of Health and Human Services, Public Health Service, Centres for Diseases Control.
11. S. Das, C. Varalakshmi, A.L. Kumari, M. Patel, and A. Khar Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function Cancer Immunol. Immunother. 50 2001 428 436
12. I.A. De Bruijn, E.J. Remarque, C.M. Jol-Van der Zijde, M.J. Mvan Tol, R.G. Westendrop, and D.L. Knoock Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination J. Infect. Dis. 179 1999 31 36
13. + cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay Clin. Diagn. Lab. Immunol. 9 2002 230 235
14. F.A. Ennis, A. Meager, A.S. Beare, D. Riley, G. Schwarz, G.C. Schild, and A.H. Rook Interferon induction and increased natural killer activity in influenza infections in man Lancet II 1981 891 893
15. L.M. Fawaz, E. Sharif-Askari, and J. Menezes Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study J. Immunol. 163 1999 4473 4480
16. C. Franceschi, M. Bonafe, and S. Valensin Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space Vaccine 18 2000 1717 1720
17. G.J. Gorse, E.E. Otto, C.C. Daughaday, F.K. Newman, C.S. Eickhoff, D.C. Powers, and R.H. Lusk Influenza virus vaccination of patients with chronic lung disease J Chest 112 1997 1221 1233
18. S. Gravenstein, P.J. Drinka, E.H. Duthie, B.A. Miller, C.S. Brown, M. Hensley, R. Circo, E. Langer, and W.B. Ershler Efficiacy of an influenza hemagglutinin-diphteria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak J. Am. Geriatr. Soc. 42 1994 245 251
19. P.A. Gross, C. Russo, M. Teplitzky, S. Dran, P. Cataruozolo, and G. Munk Time peak serum antibody response to influenza vaccine in the elderly Clin. Diagn. Lab. Immunol. 3 1996 361 362
20. G. Guanti, S. Massar, G. Cristofaro, M.L. Caruso, R. Porsia, A. Stella, F. Susca, A. Tauro, and I. Giorgio Depressed level of natural killer cells in cancer family syndrome Cancer Immunol. Immunother. 30 1989 307 311
21. T. Hussell, and P.J.M. Openshaw Intracellular INFγ expression in natural killer cells precedes lung CD8 T cell recruitment during respiratory syncytial virus infection J. Gen. Virol. 79 1998 2593 2601
22. H. Ikematsu, A. Nabeshima, C. Yong, J. Hayashi, S.O.T. Goto, H. Hara, and S. Kashiwagi The efficacy of influenza vaccine among geriatric inpatients Kansenshogaku Zasshi 74 2000 17 23
23. J.K. Kieckolt-Glaser, R. Glaser, S. Gravenstein, W.B. Malarkey, and J. Sheridan Chronic stress alters the immune response to influenza virus vaccine in older adults Proc. Natl Acad. Sci. USA 93 1996 3043 3047
24. F.J. Kos, and E.G. Engleman Requirement for natural killer cells in the induction of cytotoxic T cells J. Immunol. 1555 1995 578 584
25. M.A. Kubiet, R.J. Gonzales-Rothi, R. Cottey, and B.S. bender Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids Chest 110 1996 367 370
26. J. Kutza, P. Gross, D. Kaye, and D.M. Murasko Natural killer cell cytotoxicity in elderly humans after influenza immunization Clin. Diagn. Lab. Immunol. 3 1996 105 108
27. S.M. Levy, R.B. Herberman, J. Lee, T. Whiteside, M. Beadle, L. Heiden, and A. Simons Persistently low natural killer cell activity, age and environmental stress as predictors of infectious morbidity Nat. Immun. Cell Growth Regul. 10 1991 289 307
28. O. Mandelboim, N. Lieberman, M. Lev, L. Paul, T.J. Arnon, Y. Bushkin, and A.M. Davis Recognition of hemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells Nature 409 2001 1055 1060
29. J.E. McElhaney, S. Gravenstein, C.M. Upshaw, J.W. Hooton, P. Krause, and P. Drinka Immune response to influenza vaccination in institutionalised elderly: effect on different T-cell subsets Vaccine 16 1998 403 409
30. M. Moutaftsi, A.M. Mehl, L.K. Borysiewicz, and Z. Tabi Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells Blood 99 2002 2913 2921
31. J. Myśliwska, E. Bryl, T. Chodnik, J. Foerster, and A. Myśliwski Level of NK cytotoxic activity in the elderly aged more than 80 years Arch. Gerontol. Geriatr. 15 1992 21 28
32. A. Myśliwski, J. Myśliwska, T. Chodnik, J. Bigda, E. Bryl, and J. Foerster Elderly high NK responders are characterized by intensive proliferative response to PHA and Con A and optimal health status Arch. Gerontol. Geriatr. 16 1993 199 205
33. J. Myśliwska, E. Bryl, J. Foerster, and A. Myśliwski The upregulation of TNF (production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life Mech. Ageing Dev. 107 1999 1 14
34. K.B. Nguyen, T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron Coordinated and distinct roles for IFN-alpha beta, IL12 and IL15 regulation of NK cell responses to viral infection J. Immunol. 169 2000 4279 4387
35. K.L. Nichol, J. Wouremna, and T. von Sternberg Benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens Arch. Int. Med. 158 1998 1769 1776
36. M.F. Odelin, B. Pozzetto, M. Aymar, M. Defaydle, and J. Jolly-Milon Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data Gerontology 39 1993 109 116
37. K. Ogasawara, S.K. Yoshinaga, and L.L. Lanier Inducible costimulator costimulates cytotoxic activity and IFNγ production in activate murine NK cells J. Immunol. 169 2002 3676 3685
38. K. Ogata, E. An, Y. Shioi, K. Nakamura, S. Luo, N. Yokose, S. Minamis, and K. Dank Association between natural killer cell activity and infection in immunologically normal elderly people Clin. Exp. Immunol. 124 2001 392 397
39. J.M. Potter, B. O'Donell, W.F. Carman, M.A. Roberts, and D.Y. Stolt Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care Age Ageing 28 1999 141 145
40. M. Saurwein-Teissl, T.L. Lung, F. Marx, C. Gschosser, E. Asch, L. Blasco, W. Parson, G. Bock, D. Schonitzer, E. Trannoy, and B. Grubeck-Loebenstein Lack of antibody production following immunization in old age: association with CD+CD28- T cell clonal expansions and an imbalance in the production of TH1 and TH2 cytokines J. Immnol. 168 2002 5893 5899
41. J.M. Schapiro, Y. Segev, L. Rannon, M. Alkan, and B. Rager-Zisman Natural killer (NK) cell response after vaccination of volunteers with killed influenza vaccine J. Med. Virol. 30 1990 196 200
42. S. Thronton, K.A. Kuhn, F.D. Finkelman, and R. Hirsch NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL2 Eur. J. Immunol. 11 2001 3355 3360
43. P. Trzonkowski, J. Myśliwska, E. Szmit, J. Wieckiewicz, K. łukaszuk, L.B. Brydak, M. MachaŁa, and A. Myśliwski Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinin during the anti-influenza vaccination - an impact of immunosenescence Vaccine 21 2003 3826 3836
44. Q. Vos, M.S. Clifford, and J.J. Mond Heterogeneity in the ability of cytotoxic murine NK cell clones to enhance Ig secretion in vitro Int. Immunol. 1 1999 159 168
45. E.C. Wang, J. Taylor-Wiedeman, P. Perera, J. Fisher, and L.K. Borysiewicz Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses Clin. Exp. Immunol. 94 1993 297 305
46. H.S. Warren, B.F. Kinnear, J.H. Phillips, and L.L. Lanier Production of IL5 by human NK cells and regulation of its secretion by IL4, IL10 and IL12 J. Immunol. 154 1995 5144 5152